IN2015DN03306A - - Google Patents
Info
- Publication number
- IN2015DN03306A IN2015DN03306A IN3306DEN2015A IN2015DN03306A IN 2015DN03306 A IN2015DN03306 A IN 2015DN03306A IN 3306DEN2015 A IN3306DEN2015 A IN 3306DEN2015A IN 2015DN03306 A IN2015DN03306 A IN 2015DN03306A
- Authority
- IN
- India
- Prior art keywords
- compositions
- present
- allergen
- immunotherapy
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
Abstract
The present invention relates to compositions which can be used in immunotherapy and especially to compositions which can be used in immunotherapy for mammals suffering from a peanut allergy. The present invention further relates to the use of the present compositions for the treatment of a mammal suffering from an allergy by immunotherapy and the use of the present compositions in a prophylactic treatment for desentizing the immune system of a mammal for an allergen. Specifically, the present invention relates compositions suitable for immunotherapy comprising an allergen, wherein substantially 100% of said allergen in said composition is complexed with aluminum. The allergen , e.g. peanut kernel protein extract , is preferably reduced and alkylated in these compositions.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2012/070810 WO2014060049A1 (en) | 2012-10-19 | 2012-10-19 | Compositions for immunotherapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN03306A true IN2015DN03306A (en) | 2015-10-09 |
Family
ID=47071270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3306DEN2015 IN2015DN03306A (en) | 2012-10-19 | 2012-10-19 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20150250870A1 (en) |
| EP (1) | EP2908857B1 (en) |
| JP (1) | JP6336458B2 (en) |
| CN (1) | CN104822388A (en) |
| AU (1) | AU2012392291B2 (en) |
| CA (1) | CA2888293C (en) |
| DK (1) | DK2908857T3 (en) |
| ES (1) | ES2645740T3 (en) |
| HK (1) | HK1212206A1 (en) |
| HU (1) | HUE034729T2 (en) |
| IN (1) | IN2015DN03306A (en) |
| PL (1) | PL2908857T3 (en) |
| PT (1) | PT2908857T (en) |
| WO (1) | WO2014060049A1 (en) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2594123B2 (en) * | 1987-09-12 | 1997-03-26 | 株式会社林原生物化学研究所 | Desensitizer |
| JP2838800B2 (en) * | 1989-09-02 | 1998-12-16 | 株式会社林原生物化学研究所 | Desensitizer |
| DE122007000087I1 (en) * | 1998-10-16 | 2008-03-27 | Glaxosmithkline Biolog Sa | ADJUVANCY SYSTEMS AND VACCINES |
| CA2624503A1 (en) * | 2005-10-04 | 2007-04-12 | Alk-Abello A/S | Solid vaccine formulation |
| ES2370043T3 (en) * | 2007-03-28 | 2011-12-12 | Alk-Abelló A/S | USE OF A COADYUVADA ALLERGY VACCINE FORMULATION FOR SUBCUTANEOUS ADMINISTRATION. |
| FR2924349B1 (en) * | 2007-12-03 | 2010-01-01 | Dbv Tech | ALLERGEN DISENSIBILITY METHOD |
| EP2140880B1 (en) * | 2008-07-04 | 2012-11-14 | HAL Allergy Holding B.V. | Modification of allergens |
| US20100086568A1 (en) * | 2008-08-05 | 2010-04-08 | Koppelman Stefan Johan | Modification of allergens |
| WO2010043675A1 (en) * | 2008-10-15 | 2010-04-22 | Alk-Abelló A/S | Pharmaceutical product for up-dosing of allergy vaccine |
| WO2013087119A1 (en) * | 2011-12-16 | 2013-06-20 | Hal Allergy Holding B.V. | Pharmaceutical formulations and the use thereof for the treatment of peanut allergy |
-
2012
- 2012-10-19 JP JP2015537154A patent/JP6336458B2/en active Active
- 2012-10-19 WO PCT/EP2012/070810 patent/WO2014060049A1/en active Application Filing
- 2012-10-19 CA CA2888293A patent/CA2888293C/en active Active
- 2012-10-19 ES ES12775680.7T patent/ES2645740T3/en active Active
- 2012-10-19 EP EP12775680.7A patent/EP2908857B1/en active Active
- 2012-10-19 AU AU2012392291A patent/AU2012392291B2/en active Active
- 2012-10-19 DK DK12775680.7T patent/DK2908857T3/en active
- 2012-10-19 US US14/435,262 patent/US20150250870A1/en not_active Abandoned
- 2012-10-19 PT PT127756807T patent/PT2908857T/en unknown
- 2012-10-19 PL PL12775680T patent/PL2908857T3/en unknown
- 2012-10-19 IN IN3306DEN2015 patent/IN2015DN03306A/en unknown
- 2012-10-19 HU HUE12775680A patent/HUE034729T2/en unknown
- 2012-10-19 CN CN201280076530.3A patent/CN104822388A/en active Pending
-
2015
- 2015-12-22 HK HK15112603.7A patent/HK1212206A1/en unknown
-
2020
- 2020-06-03 US US16/891,208 patent/US20200289642A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012392291A1 (en) | 2015-05-07 |
| PL2908857T3 (en) | 2018-05-30 |
| US20200289642A1 (en) | 2020-09-17 |
| US20150250870A1 (en) | 2015-09-10 |
| CA2888293C (en) | 2018-11-06 |
| EP2908857B1 (en) | 2017-08-09 |
| CA2888293A1 (en) | 2014-04-24 |
| CN104822388A (en) | 2015-08-05 |
| ES2645740T3 (en) | 2017-12-07 |
| JP6336458B2 (en) | 2018-06-06 |
| JP2015534955A (en) | 2015-12-07 |
| AU2012392291B2 (en) | 2017-12-07 |
| WO2014060049A1 (en) | 2014-04-24 |
| DK2908857T3 (en) | 2017-11-20 |
| HK1212206A1 (en) | 2016-06-10 |
| HUE034729T2 (en) | 2018-02-28 |
| PT2908857T (en) | 2017-09-11 |
| EP2908857A1 (en) | 2015-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2013MN01582A (en) | ||
| UA112416C2 (en) | FAP ANTIBODY AND METHODS OF ITS APPLICATION | |
| BR112015020516A2 (en) | immunotherapy compositions and methods | |
| MX2016006316A (en) | Mtor inhibitors for enhancing the immune response. | |
| MX2015003416A (en) | Method for enhancing specific immunotherapies in cancer treatment. | |
| EA202193044A2 (en) | METHODS OF TREATMENT OF TAUPATHY | |
| IN2014DN10386A (en) | ||
| EP3725811A3 (en) | Compositions for inhibiting masp-2 dependent complement activation | |
| IN2014MN01642A (en) | ||
| MX346500B (en) | Methods and compositions for neural disease immunotherapy. | |
| TN2012000366A1 (en) | Anticoagulant antidotes | |
| IN2014DN08721A (en) | ||
| EA201391773A1 (en) | CELLS-PRECURSORS OF THE MESODERMAL LINE | |
| PH12014501410A1 (en) | Compositions and methods for antibodies targeting factor p | |
| MX2015001553A (en) | Compositions and methods for reducing blood alcohol content. | |
| WO2012109238A3 (en) | Methods for increasing immune responses using agents that directly bind to and activate ire-1 | |
| MY161390A (en) | Compositions and methods containing alkylglycosides for stabilizing protein-containing formulations | |
| CA2905610C (en) | Hyaluronic acid derivatives | |
| MY161868A (en) | Anti-bv8 antibodies and uses thereof | |
| WO2013072901A3 (en) | Compositions and methods for treating glioma | |
| MX362175B (en) | Use of p3 of bacteriophage as amyloid binding agents. | |
| MX2013002960A (en) | Antibody compositions and methods of use. | |
| GB2459609A (en) | Methods for allergen detection | |
| MX2014004326A (en) | ANTIBODIES TO CD1d. | |
| TN2013000388A1 (en) | Anticoagulant antidotes |